换一批
换一批Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI).
作者：
主题词
动物(Animals);抗原呈递(Antigen Presentation);抗原呈递细胞(Antigen-Presenting Cells);抗原, 肿瘤(Antigens, Neoplasm);乳腺肿瘤(Breast Neoplasms);细胞分化(Cell Differentiation);细胞因子诱导杀伤细胞(Cytokine-Induced Killer Cells);女(雌)性(Female);基因, MHCⅠ类(Genes, MHC Class I);HLA抗原(HLA Antigens);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);Kaplan-Meiers评估(Kaplan-Meier Estimate);杀伤细胞, 淋巴因子激活(Killer Cells, Lymphokine-Activated);杀伤细胞, 天然(Killer Cells, Natural);肺肿瘤(Lung Neoplasms);淋巴细胞活化(Lymphocyte Activation);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);巨噬细胞(Macrophages);小鼠(Mice);小鼠, 裸(Mice, Nude);单核细胞(Monocytes);受体CD3复合物, 抗原, T细胞(Receptor-CD3 Complex, Antigen, T-Cell);T细胞抗原受体特异性(T-Cell Antigen Receptor Specificity);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.2217/imt.14.6
PMID
24762072
发布时间
2015-11-19
- 浏览66
Immunotherapy
269-82页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
